Role of Nanotechnology in Ischemic Stroke: Advancements in Targeted Therapies and Diagnostics for Enhanced Clinical Outcomes
Journal of Functional Biomaterials,
Год журнала:
2025,
Номер
16(1), С. 8 - 8
Опубликована: Янв. 1, 2025
Each
year,
the
number
of
cases
strokes
and
deaths
due
to
this
is
increasing
around
world.
This
could
be
work
stress,
lifestyles,
unhealthy
food
habits,
several
other
reasons.
Currently,
there
are
traditional
methods
like
thrombolysis
mechanical
thrombectomy
for
managing
strokes.
The
current
approach
has
limitations,
delayed
diagnosis,
limited
therapeutic
delivery,
risks
secondary
injuries.
So,
a
need
some
effective
reliable
management
strokes,
which
help
in
early
diagnosis
followed
by
treatment
Nanotechnology
played
an
immense
role
recently,
it
emerged
as
transformative
solution
offering
innovative
diagnostic
tools
strategies.
Nanoparticles
(NPs)
belonging
classes,
including
metallic
(metallic
metal
oxide),
organic
(lipids,
liposome),
carbon,
can
cross
blood–brain
barrier
may
exhibit
potential
various
Moreover,
these
NPs
have
exhibited
promise
improving
imaging
specificity
delivery
precise
drug
real-time
monitoring
efficacy.
Nanomaterials
cerium
oxide
(CeO2)
liposome-encapsulated
agents
neuroprotective
properties
that
reduce
oxidative
stress
promote
neuroregeneration.
In
present
article,
authors
emphasized
significant
advancements
nanomedicine
stroke,
NPs-based
systems,
neuroregenerative
therapies,
multimodal
advancements.
Язык: Английский
Nanoparticle Strategies for Treating CNS Disorders: A Comprehensive Review of Drug Delivery and Theranostic Applications
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(24), С. 13302 - 13302
Опубликована: Дек. 11, 2024
This
review
aims
to
address
the
significant
challenges
of
treating
central
nervous
system
(CNS)
disorders
such
as
neurodegenerative
diseases,
strokes,
spinal
cord
injuries,
and
brain
tumors.
These
are
difficult
manage
due
complexity
disease
mechanisms
protective
blood–brain
barrier
(BBB),
which
restricts
drug
delivery.
Recent
advancements
in
nanoparticle
(NP)
technologies
offer
promising
solutions,
with
potential
applications
delivery,
neuroprotection,
neuroregeneration.
By
examining
current
research,
we
explore
how
NPs
can
cross
BBB,
deliver
medications
directly
targeted
CNS
regions,
enhance
both
diagnostics
treatment.
Key
NP
strategies,
passive
targeting,
receptor-mediated
transport,
stimuli-responsive
systems,
demonstrate
encouraging
results.
Studies
show
that
may
improve
minimize
side
effects,
increase
therapeutic
effectiveness
models
Alzheimer’s,
Parkinson’s,
stroke,
glioblastoma.
thus
represent
a
approach
for
disorder
management,
combining
delivery
diagnostic
capabilities
enable
more
precise
effective
treatments
could
significantly
benefit
patient
outcomes.
Язык: Английский
Targeting tumor microenvironment with RGD-functionalized nanoparticles for precision cancer therapy
Cancer Letters,
Год журнала:
2025,
Номер
unknown, С. 217536 - 217536
Опубликована: Фев. 1, 2025
Язык: Английский
Polymer-based nanocarriers to transport therapeutic biomacromolecules across the blood-brain barrier
Acta Biomaterialia,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 1, 2025
Therapeutic
biomacromolecules
such
as
genetic
material,
antibodies,
growth
factors
and
enzymes
represent
a
novel
therapeutic
alternative
for
neurological
diseases
disorders.
In
comparison
to
traditional
therapeutics,
which
are
mainly
based
on
small
molecular
weight
drugs
that
address
the
symptoms
of
these
disorders,
can
reduce
undesired
side
effects
target
specific
pathological
pathways,
thus
paving
way
towards
personalized
medicine.
However,
undergo
degradation/denaturation
processes
in
physiological
environment
show
poor
capacity
cross
blood-brain
barrier
(BBB).
Consequently,
they
rarely
reach
central
nervous
system
(CNS)
their
active
form.
Herein,
we
critically
overview
several
polymeric
nanocarriers
protect
deliver
across
BBB.
Polymeric
first
categorized
architecture
(biodegradable
solid
nanoparticles,
nanogels,
dendrimers,
self-assembled
nanoparticles),
ultimately
determines
physico-chemical
properties
function.
The
available
formulations
then
thoroughly
analyzed,
placing
particular
attention
those
strategies
ensure
stability
during
encapsulation
process
promote
passage
BBB
by
controlling
physical
(e.g.,
mechanical
properties,
size,
surface
charge)
chemical
functional
groups,
targeting
motifs)
properties.
Accordingly,
this
review
gives
unique
perspective
delivery
BBB,
representing
concise,
complete
easy-to-follow
guide,
will
be
high
interest
chemists,
material
scientists,
pharmacologists
biologists.
Besides,
it
also
provides
critical
about
limited
clinical
translation
systems.
STATEMENT
OF
SIGNIFICANCE:
increasing
incidence
disorders
is
major
health
concern.
use
has
been
placed
spotlight
many
investigations.
reaching
concentration
levels
restricted
and,
thus,
represents
main
challenge
when
developing
efficient
therapies.
provide
discussion
into
system,
highlighting
potential
future
directions
overcome
current
challenges.
Язык: Английский
Molecularly imprinted nanoparticles hitchhiking on neutrophils for precise treatment of ischemic stroke
Journal of Colloid and Interface Science,
Год журнала:
2025,
Номер
689, С. 137246 - 137246
Опубликована: Март 4, 2025
Язык: Английский
Enhanced Vitamin D3 Adsorption Through Novel Hydrophobic Halloysite–Alginate Biopolymer Composites
Polymers,
Год журнала:
2025,
Номер
17(8), С. 1083 - 1083
Опубликована: Апрель 17, 2025
This
study
presents
a
sustainable
strategy
to
enhance
polymer
encapsulation,
adsorption,
and
functional
properties
by
chemically
modifying
sodium
alginate
with
hydrophobic
groups.
Hydrophobic
derivatives
were
synthesized
via
solvent-free
method
using
hexadecyl
trimethylammonium
bromide,
resulting
in
nanoparticles
capable
of
effectively
capturing
non-polar
compounds.
To
further
improve
compatibility
within
alginate-based
biocomposites,
halloysite
nanotubes
modified
through
ball
milling
surfactant-assisted
treatments.
The
nanocomposites
(MBHA
MHHA)
exhibited
significantly
enhanced
adsorption
controlled
release
behavior,
as
confirmed
FTIR
analysis
ester
conjugation.
Vitamin
D3
followed
the
Langmuir
isotherm,
high
correlation
coefficients
(R2
=
0.998
for
MBHA
R2
0.991
MHHA),
indicating
monolayer
on
homogenous
surface.
Kinetic
modeling
revealed
that
process
adhered
pseudo-second-order
model
0.9969
0.999
suggesting
chemisorption
was
dominant
rate-controlling
mechanism.
These
results
demonstrate
critical
role
surface
modification
designing
nano-engineered
biopolymers
superior
stability,
profiles,
offering
applications
medicine,
agriculture,
environmental
remediation.
Язык: Английский
ROS-responsive Chitosan Bilirubin Nanoparticles loaded with Statin for Treatment of Cerebral Ischemia
Biomaterials Research,
Год журнала:
2024,
Номер
28
Опубликована: Янв. 1, 2024
Cerebral
ischemia
impairs
blood
circulation,
leading
to
elevated
reactive
oxygen
species
(ROS)
production.
A
ROS-responsive
delivery
of
drugs
can
enhance
the
therapeutic
efficacy
and
minimize
side
effects.
There
is
insufficient
evidence
on
impact
nanoparticles
ischemic
stroke.
We
developed
chitosan–bilirubin
(ChiBil)
target
acute
lesions
investigated
effect
atorvastatin-loaded
ChiBil.
randomly
assigned
rats
with
transient
middle
cerebral
artery
occlusion
(MCAO)
4
groups:
saline,
Statin,
ChiBil,
ChiBil-Statin.
These
groups
were
treated
daily
via
tail
vein
for
7
d.
Behavioral
assessment,
magnetic
resonance
(MR)
imaging,
evaluation
neuroinflammation,
blood–brain
barrier
(BBB)
integrity,
apoptosis,
neurogenesis
after
stroke
conducted.
In
vitro,
results
showed
nanoparticle
uptake
reduced
intracellular
ROS,
lipid
peroxidation,
inflammatory
cytokines
(IL-6
TNF-α).
vivo,
improved
motor
deficits
decreased
infarct
volumes
MR
images
in
ChiBil-Statin
group
compared
Control
day
(
P
<
0.05).
Furthermore,
expression
such
as
IL-1β
IL-6
was
Improvements
BBB
observed
group.
The
findings
demonstrated
that
intravenous
multifunctional
could
effectively
deliver
brain,
exerting
marked
synergistic
pleiotropic
neuroprotective
Therefore,
holds
promise
a
targeted
therapy
vascular
diseases
characterized
by
increased
ROS
production,
new
avenues
future
research
potential
clinical
applications.
Язык: Английский
Current Status of Research on Nanomaterials Combined with Mesenchymal Stem Cells for the Treatment of Ischemic Stroke
NeuroMolecular Medicine,
Год журнала:
2024,
Номер
26(1)
Опубликована: Дек. 7, 2024
Язык: Английский
Dual-stimuli responsive nanoparticles for co-delivery of small molecules to promote neural differentiation of human iPSCs
Nanoscale,
Год журнала:
2024,
Номер
unknown
Опубликована: Дек. 23, 2024
The
differentiation
of
human
induced
pluripotent
stem
cells
(hiPSCs)
into
neural
progenitor
(NPCs)
is
a
promising
approach
for
the
treatment
neurodegenerative
diseases
and
regenerative
medicine.
Язык: Английский